Comparative analysis of the performance of the large language models ChatGPT-3.5, ChatGPT-4 and Open AI-o1 in the field of Programmed Cell Death in myeloma

Open AI-o1 outperforms ChatGPT-3.5 and ChatGPT-4 in accuracy, depth, and reliability when addressing complex clinical questions related to Programmed Cell Death in multiple myeloma. Its advanced "thinking" ability facilitates comprehensive and evidence-based responses, making it a more dependable tool for clinical decision support. These findings suggest that Open AI-o1 holds significant potential for enhancing clinical practices in specialized oncological fields, though ongoing validation and integration with human expertise remain essential.